Laman UtamaGIFOF • OTCMKTS
add
Grifols SA Preference Shares Class B
Tutup sebelumnya
$7.42
Julat tahun
$5.58 - $9.40
Permodalan pasaran
5.97B USD
Bilangan Purata
10.00
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(EUR) | Sep 2024info | Perubahan T/T |
---|---|---|
Hasil | 1.79B | 12.24% |
Perbelanjaan pengendalian | 376.78J | -3.08% |
Pendapatan bersih | 51.69J | -13.19% |
Margin untung bersih | 2.88 | -22.79% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 468.09J | 33.73% |
Kadar cukai berkesan | 31.35% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(EUR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 806.74J | 66.60% |
Jumlah aset | 20.28B | -8.07% |
Jumlah liabiliti | 12.29B | -8.95% |
Jumlah ekuiti | 8.00B | — |
Syer tertunggak | 679.63J | — |
Harga kepada buku | 0.94 | — |
Pulangan pada aset | 4.22% | — |
Pulangan pada modal | 4.78% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(EUR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 51.69J | -13.19% |
Tunai daripada operasi | 299.61J | 92.51% |
Tunai daripada pelaburan | -196.40J | -59.83% |
Tunai daripada pembiayaan | -1.56B | -1,860.81% |
Perubahan bersih dalam tunai | -1.47B | -3,652.69% |
Aliran tunai bebas | 243.60J | 627.76% |
Perihal
Grifols, S.A. is a global healthcare company and manufacturer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,000employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30.
Principally a producer of blood plasma–based products, a field in which it is the European leader and third largest worldwide, and other biopharmaceutical solutions, the company is also a leader in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, in addition to clinical diagnostic technologies. Its portfolio of solutions is designed to enhance safety from donation to transfusion. Grifols also provides high-quality biological supplies for life-science research, clinical trials and for manufacturing pharmaceutical and diagnostic products. Additionally, the company supply tools, information and services that enable hospitals, pharmacies and healthcare professionals to deliver expert medical care. Wikipedia
CEO
Diasaskan
18 Nov 1940
Tapak web
Pekerja
23,000